Search

everythinglearnresearchcommunity

for

Search:↓

Researchers developed a new skin patch that delivers more finasteride into the skin, potentially improving treatment for hair loss and prostate issues.

Liposomes improve drug delivery and reduce skin irritation in dermatology.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Smaller particles of the drug carrier penetrated skin better, with 300 nm size being best for targeting hair follicles.

Sirtuin 1 could be a potential drug target for treating hypertrophic scars.

Researchers found new potential but less potent rat enzyme inhibitors using a 3D model.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

The formula YH0618 can reduce the harmful side effects of the chemotherapy drug Doxorubicin and protect healthy cells.

Finasteride reduces melanin production, possibly treating hyperpigmentation and melanoma, but needs more safety research.

Ethosomes improve drug delivery through the skin and show promise for treating male pattern baldness.

Researchers used a laser to create advanced skin models with hair-like structures.

The conclusion is that a new test was created to find substances that affect specific ion channels, and it works well for drug discovery.

Scientists found a new gene in a bacterium that can modify an immunosuppressant drug, potentially helping to treat hair loss.

3D spheroid cultures of human hair follicle cells are better for hair growth research than 2D cultures, and they provide new insights into how hair growth treatments like minoxidil and TCQA work.

Researchers developed a simple and accurate method to measure Minoxidil in tablets using UV light.

Orphan drug benefit scores in Germany are influenced by phase III data and lack of alternatives, but not linked to price or discounts.

Researchers developed a method to create artificial hair follicles that may help with hair loss treatment and research.

The model and estimator can predict drug exposure in kidney transplant patients well.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

The document concludes that more research is needed to understand how to treat muscle pain with drugs.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Male hormones affect oil-producing skin cells differently based on their body location, and the drug spironolactone can reduce these effects.

Latanoprost, a glaucoma drug, showed potential for promoting hair growth in bald monkeys, especially at higher doses.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

A cancer drug called nilotinib might cause hair loss due to inflammation around hair follicles.

Topical minoxidil might potentially cause vision problems, but more research is needed.

Tridax procumbens shows potential for various health benefits but needs more scientific research.

Metatrials could improve clinical research in nephrology by speeding up data collection and overcoming challenges like patient recruitment.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

The issue discussed China's research contributions, systematic review improvements, and featured various medical studies and trials.